Routing a Security Question During Healthcare Commercial Discovery

A security question during discovery is not a technical problem, it is a relationship moment. The buyer is testing whether you will overpromise, deflect, or actually route them to the right people. Handle it well and you keep the deal moving. Handle it poorly and you either stall the conversation or make a claim your security team has to walk back later.

Why This Conversation Goes Wrong

Account executives get asked security questions during healthcare discovery calls all the time, and one of two things usually goes wrong. Under pressure to keep the deal moving, some reps guess at the answer, they say the platform is HIPAA compliant, or they promise a document exists before checking. Compliance officers hear that and start treating the vendor as unreliable, not because the platform lacks security, but because the person representing it spoke past their authority.

Other reps do the opposite. They freeze the moment security comes up and say they need to check with someone before answering anything at all, which reads as evasive even when it is honest. The buyer is not asking you to personally certify the system. They are asking you to run their review process correctly and get the right specialist involved quickly. That distinction matters, and most reps have never had it explained to them plainly.

Healthcare buyers also carry more at stake than buyers in most other industries. A hospital system or a health plan answers to regulators, to their own compliance department, and often to a board that has seen a vendor breach make the news. So a vague or overconfident answer costs you more here than it would in a lower stakes sale. This is one reason Healthcare practice conversations look different from generic sales conversations, the reader has to manage regulatory weight in the room even during an early stage call.

How To Prepare Before The Question Comes Up

Prepare for a security question before it lands, not after. Walk into every healthcare discovery call already knowing three things. First, know your own company's approved review process, meaning who your security and privacy team is, what materials they have already cleared for release, and how those materials get shared securely. Second, know that you personally are not authorized to interpret regulatory obligations for the buyer, and settle in your mind that you will not try. Third, keep a short brief ready that captures who owns the review on the buyer's side, which questionnaire or document set they use, and when they need it completed.

That brief does real work. It turns a vague request into a set of specific facts your security team can act on immediately instead of asking you to go find. When you can hand your internal specialist a name, a document format, and a date, the review moves fast. When you hand them nothing but "they asked about security," the specialist has to reopen the conversation with the buyer, and that delay reads as disorganization on your side, not theirs.

It helps to treat this the same way you treat the discovery questions covered in Starting Healthcare Commercial Discovery With Workflow Questionswhere the goal is pulling out concrete detail early rather than letting the conversation stay abstract. A security question deserves the same treatment. Get specific fast.

What To Say When The Question Comes Up

Say what your role actually covers, then move the buyer toward the process that answers their real question.

In one such exchange, a compliance lead named Priya opens with, "Before we schedule a demo, send over proof that your system meets every one of our security requirements." A rep named Marcus answers, "Our security team can walk through the documented requirements through our standard review process. Which team on your side owns the questionnaire, and what date do you need it back by." Priya says, "Our privacy officer will need to be part of that conversation as well." Marcus replies, "I will bring in the right specialists on our side and send the approved materials through whatever channel your team uses for this. In the meantime, we can keep the demo focused on the clinical workflow, and let the review run in parallel."

Notice what Marcus never does. He never says the system meets every requirement, because he cannot verify that claim in the moment and should not guess. He never names a certification the company may or may not hold. He never tells Priya what her own privacy obligations require, because that is her call, not his. What he does instead is concrete, he identifies the owner, confirms a date, and keeps the commercial conversation alive by separating the security review from the demo.

That last move matters more than it looks. Buyers sometimes hold the whole deal hostage to security clearance without meaning to, mostly because no one offered them another path. Splitting the workflow conversation from the security review respects the buyer's process while keeping the deal from stalling for weeks.

Mistakes That Slow Down Or Sink The Review

The most common mistake is answering the compliance question with confidence you have not earned. Saying the platform is fully compliant, or that it meets a specific regulation, without your security team's sign off puts a claim in the buyer's notes that someone will eventually have to defend or retract. Retracting a claim damages trust far more than saying "let me confirm that with the right team" ever would.

A second mistake is treating the request as purely administrative and forgetting to loop in your own security or privacy specialist quickly. Every day that request sits unassigned is a day the buyer wonders whether your company takes their review seriously.

A third mistake is losing track of what business decision actually depends on the review. Reps sometimes let the security thread run on its own track for weeks without asking what happens to the deal once it clears. Capture that connection early, ask what changes for the buyer once the review is done, so the specialist conversation stays tied to an actual purchase decision instead of becoming an open ended compliance exercise.

How To Practice And Score This Conversation

This conversation rewards rehearsal more than most, because the mistakes are easy to make live and hard to notice in the moment. A manager can run a short roleplay where they play a skeptical compliance officer and push on vague answers the way a real buyer would. Listen for any sentence that sounds like an unverified guarantee, a claim about a certification, or an opinion about what the buyer's own regulations require. Any of those should get flagged and rewritten on the spot.

Score the rep on three things. Did they identify the buyer's review owner and target date. Did they avoid making a claim outside their authority. Did they keep the commercial conversation moving instead of letting the request stall the whole deal. A rep who nails the first two but freezes on the third has learned caution without learning momentum, and that gap is worth coaching.

DealSpeak's healthcare scenarios let you rehearse this exact exchange against an AI counterpart that pushes back the way a real compliance officer would, and get scored against these same criteria. The healthcare library covers a range of situations beyond discovery calls too, including the workflow questions in the discovery post above and even patient facing scenarios like Helping a Patient Manage Too Many Appointmentsso a rep or a clinician can build the same muscle for handling pressure without guessing.

Getting this right is not about memorizing a script. It is about knowing exactly what you are and are not authorized to say, and having the process details ready before the question ever comes up. Practice it enough times and the moment stops feeling like a test you might fail.